Ezetimibe And Simvastatin
Product Images NDC 42291-078

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ezetimibe And Simvastatin (NDC 42291-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

78 (078 10)

Label for Ezetimibe and Simvastatin Tablets 10 mg/10 mg by AvKARE. The label states each tablet contains 10 mg ezetimibe USP and 10 mg simvastatin USP. It includes storage instructions to keep at 20° to 25°C and a note to dispense in a tightly closed container. The label also indicates the product is prescription only and available in a package of 1,000 tablets.*

FDA Label Image

79 (079 10)

Label for Ezetimibe and Simvastatin Tablets 10 mg/20 mg by AvKARE. The label specifies the active ingredients with their strengths, storage instructions, manufacturer details, and a barcode. It indicates the bottle contains 1,000 tablets and includes dosage and dispensing information.*

FDA Label Image

80 (080 10)

Label for Ezetimibe and Simvastatin Tablets 10 mg/40 mg by AvKARE. The label details that each tablet contains 10 mg ezetimibe USP and 40 mg simvastatin USP. Packaging mentions prescription only, 1,000 tablets, storage instructions, manufacturer information including Amneal Pharmaceuticals of NY, LLC, and a barcode.*

FDA Label Image

81 (081 50)

Label for Ezetimibe and Simvastatin Tablets 10 mg/80 mg manufactured for AvKARE. The label states each tablet contains 10 mg ezetimibe and 80 mg simvastatin. It indicates prescription use only, with a package size of 500 tablets. Storage instructions specify 20° to 25°C and a tightly closed container. Manufactured by Amneal Pharmaceuticals of NY, LLC.*

FDA Label Image

1 (Ezetimibe And Simvastatin Tablets 1)

Chemical structure of the active ingredients in Ezetimibe and Simvastatin, showing molecular arrangement with multiple aromatic rings, hydroxyl groups, and fluorine atoms.*

FDA Label Image

2 (Ezetimibe And Simvastatin Tablets 2)

Chemical structure diagram of the active ingredient in Ezetimibe and Simvastatin, depicting molecular bonds and functional groups characteristic of the compound.*

FDA Label Image

1 (Ezetimibe And Simvastatin Tablets 3)

A line graph comparing major vascular events (%) over five years of follow-up between placebo and Ezetimibe/Simvastatin (Ezs) treatment groups. The graph shows patient event percentages on the vertical axis and years on the horizontal axis, with statistical significance (P=0.001) indicated. Below the graph is a table of patient numbers at risk for each group across the follow-up years.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.